Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation
Morano, F., Corallo, S., Niger, M., Barault, L., Milione, M., Berenato, R., Moretto, R., Randon, G., Antista, M., Belfiore, A., Raimondi, A., Nichetti, F., Martinetti, A., Battaglia, L., Perrone, F., Pruneri, G., Falcone, A., Di Bartolomeo, M., de Braud, F., Di Nicolantonio, F., Cremolini, C., Pietrantonio, F.
Published in Annals of oncology (01.08.2018)
Published in Annals of oncology (01.08.2018)
Get full text
Journal Article
Metronomic capecitabine plus cyclophosphamide in unresectable or relapsed pseudomyxoma peritonei
Raimondi, A., Corallo, S., Niger, M., Antista, M., Randon, G., Morano, F., Cremolini, C., Di Bartolomeo, M., de Braud, F.G.M., Pietrantonio, F.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Health-related quality of life in RAS wild-type metastatic colorectal cancer patients treated with panitumumab plus FOLFOX followed by panitumumab or panitumumab plus 5-FU/LV maintenance: the secondary endpoint of the Valentino study
Raimondi, A., Di Maio, M., Peverelli, G., Morano, F., Corallo, S., Bergamo, F., Cremolini, C., Smiroldo, V., Amatu, A., Tampellini, M., Fanchini, L., Murialdo, R., Clavarezza, M., Noventa, S., Adamo, V., Ratti, M., Petrelli, F., Antonuzzo, L., Palermo, M., de Braud, F., Di Bartolomeo, M., Pietrantonio, F.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Negative hyper-selection of RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients randomized to first-line FOLFOX plus panitumumab (Pan) followed by maintenance therapy with either 5FU/LV plus pan or single-agent pan: Translational analyses of the VALENTINO study
Morano, F., Corallo, S., Di Bartolomeo, M., Lonardi, S., Cremolini, C., Rimassa, L., Sartore Bianchi, A., Murialdo, R., Zaniboni, A., Adamo, V., Tomasello, G., Tampellini, M., Fanchini, L., Schirripa, M., Clavarezza, M., Petrelli, F., Longarini, R., Cinieri, S., de Braud, F.G.M., Pietrantonio, F.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Clinico-pathological and molecular characterization of BRAF mutant metastatic colorectal cancer (mCRC): Are all mutations created equal?
Schirripa, M., Biason, P., Cortiula, F., Pino, M., Urbano, F., Antoniotti, C., Corallo, S., Gelsomino, F., Orlandi, A., Lonardi, S., Bergamo, F., Munari, G., Malapelle, U., Rugge, M., Mescoli, C., Reggiani Bonetti, L., Lanza, G., Dei Tos, A., De Maglio, G., Zagonel, V., Loupakis, F., Fassan, M.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
First-line FOLFOX plus panitumumab followed by 5-FU/LV plus panitumumab or single-agent panitumumab as maintenance therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC): The VALENTINO study
Pietrantonio, F., Morano, F., Corallo, S., Raimondi, A., Loupakis, F., Cremolini, C., Smiroldo, V., Berenato, R., Bianchi, A. Sartore, Tampellini, M., Bustreo, S., Clavarezza, M., Murialdo, R., Zaniboni, A., Tomasello, G., Peverelli, G., Antoniotti, C., Procaccio, L., Cinieri, S., Antonuzzo, L., Di Bartolomeo, M., de Braud, F.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study
Raimondi, A., Fucà, G., Leone, A.G., Lonardi, S., Antoniotti, C., Smiroldo, V., Amatu, A., Tampellini, M., Ritorto, G., Murialdo, R., Clavarezza, M., Zaniboni, A., Berenato, R., Ratti, M., Corallo, S., Morano, F., Di Bartolomeo, M., Di Maio, M., Pietrantonio, F.
Published in ESMO open (01.10.2021)
Published in ESMO open (01.10.2021)
Get full text
Journal Article
RET rearrangements define an uncommon molecular subtype of metastatic colorectal cancer (mCRC)
Pietrantonio, F., Schrock, A.B., Lee, J., Drilon, A., Christiansen, J., Chiu, V.K., Zaniboni, A., Fucà, G., Morano, F., Borelli, B., Rossini, D., Milione, M., Corallo, S., Prisciandaro, M., Cagnazzo, C., Bardelli, A., Trusolino, L., Di Nicolantonio, F., Falcone, A., de Braud, F., Cremolini, C.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
The relationship between anatomy and electrical parameters in His bundle pacing
Coluccia, G, Senes, J, Corallo, S, Aste, M, Oddone, D, Donateo, P, Puggioni, E, Brignole, M
Published in European heart journal (12.10.2021)
Published in European heart journal (12.10.2021)
Get full text
Journal Article
Assessing risks and outcomes in liver surgery: a comprehensive analysis of 12 years of patient data
Fugazzola, P., Corallo, S., Gallotti, A., Cicerone, O., Di Gioia, G., Farè, C.N., Maiocchi, L., Ravetta, V., Anderloni, A., Maestri, M.
Published in HPB (Oxford, England) (2024)
Published in HPB (Oxford, England) (2024)
Get full text
Journal Article
O-12 Phase II study of preoperative chemoradiotherapy plus avelumab in patients with locally advanced rectal cancer: The AVANA study
Salvatore, L., Bensi, M., Corallo, S., Bergamo, F., Pellegrini, I., Rasola, C., Borelli, B., Tamburini, E., Randon, G., Galuppo, S., Boccaccino, A., Viola, M., Auriemma, A., Fea, E., Barbara, C., Corvari, B., Bustreo, S., Smiroldo, V., Barbaro, B., Tortora, G.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
SO-24 Circulating tumor DNA variant allelic fraction as a surrogate for disease burden estimation in patients with RAS wild-type metastatic colorectal cancer: A secondary endpoint of the VALENTINO study
Manca, P., Corallo, S., Lonardi, S., Corti, F., Antoniotti, C., Procaccio, L., Smiroldo, V., Tomasello, G., Murialdo, R., Pagani, F., Randon, G., Martinetti, A., Sottotetti, E., Prisciandaro, M., Ambrosini, M., Raimondi, A., Morano, F., Pietrantonio, F.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
581PMetronomic capecitabine plus cyclophosphamide in unresectable or relapsed pseudomyxoma peritonei
Raimondi, A, Corallo, S, Niger, M, Antista, M, Randon, G, Morano, F, Cremolini, C, Di Bartolomeo, M, de Braud, F G M, Pietrantonio, F
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
605P - Prognostic role of blood cell count-based immuno-inflammatory parameters in the Valentino trial
Fuca, G., Guarini, V., Corallo, S., Lonardi, S., Raimondi, A., Peverelli, G., Rimassa, L., Antoniotti, C., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Prisciandaro, M., Palermo, F., Bartolomeo, M Di, De Braud, F.G.M., Pietrantonio, F.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
605PPrognostic role of blood cell count-based immuno-inflammatory parameters in the Valentino trial
Fuca, G, Guarini, V, Corallo, S, Lonardi, S, Raimondi, A, Peverelli, G, Rimassa, L, Antoniotti, C, Murialdo, R, Zaniboni, A, Sartore-Bianchi, A, Tomasello, G, Racca, P, Clavarezza, M, Adamo, V, Prisciandaro, M, Palermo, F, Bartolomeo, M Di, Braud, F G M De, Pietrantonio, F
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Prognostic role of blood cell count-based immuno-inflammatory parameters in the Valentino trial
Fuca, G., Guarini, V., Corallo, S., Lonardi, S., Raimondi, A., Peverelli, G., Rimassa, L., Antoniotti, C., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Prisciandaro, M., Palermo, F., Bartolomeo, M Di, De Braud, F.G.M., Pietrantonio, F.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
PD-016Health-related quality of life in RAS wild-type metastatic colorectal cancer patients treated with panitumumab plus FOLFOX followed by panitumumab or panitumumab plus 5-FU/LV maintenance: the secondary endpoint of the Valentino study
Raimondi, A, Di Maio, M, Peverelli, G, Morano, F, Corallo, S, Bergamo, F, Cremolini, C, Smiroldo, V, Amatu, A, Tampellini, M, Fanchini, L, Murialdo, R, Clavarezza, M, Noventa, S, Adamo, V, Ratti, M, Petrelli, F, Antonuzzo, L, Palermo, M, de Braud, F, Di Bartolomeo, M, Pietrantonio, F
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Transdermal granisetron for the prevention of chemotherapy-induced nausea and vomiting in metastatic colorectal cancer patients with high risk of bowel obstruction treated with temozolomide
Calegari, M.A., Monterisi, S., Orlandi, A., Inno, A., Barile, R., Corallo, S., Di Dio, C., Zurlo, V., Basso, M., Cassano, A., Barone, C.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Transdermal Granisetron for the prevention of chemotherapy-induced nausea and vomiting in metastatic colorectal cancer patients with high risk of bowel obstruction treated with Temozolomide
Calegari, M.A., Monterisi, S., Orlandi, A., Inno, A., Corallo, S., Barile, R., Di Dio, C., Zurlo, V., Basso, M., Cassano, A., Barone, C.
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article